A Comprehensive Digital Care Program for Migraine Management
RecruitingNCT07642414Phase: NAStarted 2026-06
Summary
This study evaluates the clinical effectiveness of the Enso for Migraine program, a comprehensive digital care program combining an FDA-cleared neuromodulation wearable device (Enso), personalized exe
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
None
Locations
Hinge Health, Inc.San Francisco, California, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07642414